Alnylam Pharmaceuticals
ALNY
#458
Rank
โ‚ฌ45.22 B
Marketcap
342,29ย โ‚ฌ
Share price
-0.28%
Change (1 day)
35.77%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company